TrialAIDS (London, England)2011

Efficacy of a nucleoside-sparing regimen of darunavir/ritonavir plus raltegravir in treatment-naive HIV-1-infected patients (ACTG A5262).

Babafemi Taiwo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.